ISREUR
Perspective Therapeutics, Inc.
Clinical-stage radiopharmaceutical company developing targeted alpha-particle therapies (theranostics) for cancer using Lead-212.
CUSIP: 46489V104HealthcareUS1 holder
Recent Activity
2007Q4
1 sell
-1.00M shares
-1.00M shares
2007Q3
1 buy
+1.00M shares
+1.00M shares